Vratsanos G - Search Results

1

Vaccination response to tetanus toxoid and 23-valent pneumococcal vaccines following administration of a single dose of abatacept: a randomized, open-label, parallel group study in healthy subjects.

Tay L, Leon F, Vratsanos G, Raymond R, Corbo M. Tay L, et al. Among authors: vratsanos g. Arthritis Res Ther. 2007;9(2):R38. doi: 10.1186/ar2174. Arthritis Res Ther. 2007. PMID: 17425783 Free PMC article. Clinical Trial.

2

Abatacept treatment does not exacerbate chronic Mycobacterium tuberculosis infection in mice.

Bigbee CL, Gonchoroff DG, Vratsanos G, Nadler SG, Haggerty HG, Flynn JL. Bigbee CL, et al. Among authors: vratsanos g. Arthritis Rheum. 2007 Aug;56(8):2557-65. doi: 10.1002/art.22750. Arthritis Rheum. 2007. PMID: 17665452 Free article.

3

Reduction of inflammatory biomarker response by abatacept in treatment of rheumatoid arthritis.

Weisman MH, Durez P, Hallegua D, Aranda R, Becker JC, Nuamah I, Vratsanos G, Zhou Y, Moreland LW. Weisman MH, et al. Among authors: vratsanos g. J Rheumatol. 2006 Nov;33(11):2162-6. Epub 2006 Oct 1. J Rheumatol. 2006. PMID: 17014006 Clinical Trial.

4

Abatacept inhibits progression of structural damage in rheumatoid arthritis: results from the long-term extension of the AIM trial.

Genant HK, Peterfy CG, Westhovens R, Becker JC, Aranda R, Vratsanos G, Teng J, Kremer JM. Genant HK, et al. Among authors: vratsanos g. Ann Rheum Dis. 2008 Aug;67(8):1084-9. doi: 10.1136/ard.2007.085084. Epub 2007 Dec 17. Ann Rheum Dis. 2008. PMID: 18086727 Free PMC article. Clinical Trial.

5

Mode of action of abatacept in rheumatoid arthritis patients having failed tumour necrosis factor blockade: a histological, gene expression and dynamic magnetic resonance imaging pilot study.

Buch MH, Boyle DL, Rosengren S, Saleem B, Reece RJ, Rhodes LA, Radjenovic A, English A, Tang H, Vratsanos G, O'Connor P, Firestein GS, Emery P. Buch MH, et al. Among authors: vratsanos g. Ann Rheum Dis. 2009 Jul;68(7):1220-7. doi: 10.1136/ard.2008.091876. Epub 2008 Sep 4. Ann Rheum Dis. 2009. PMID: 18772191 Free PMC article.

6

Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial).

Emery P, Durez P, Dougados M, Legerton CW, Becker JC, Vratsanos G, Genant HK, Peterfy C, Mitra P, Overfield S, Qi K, Westhovens R. Emery P, et al. Among authors: vratsanos g. Ann Rheum Dis. 2010 Mar;69(3):510-6. doi: 10.1136/ard.2009.119016. Epub 2009 Nov 23. Ann Rheum Dis. 2010. PMID: 19933744 Free PMC article. Clinical Trial.

7

Surface CD152 (CTLA-4) expression and signaling dictates longevity of CD28null T cells.

Hoff H, Knieke K, Cabail Z, Hirseland H, Vratsanos G, Burmester GR, Jorch G, Nadler SG, Bröker B, Hebel K, Brunner-Weinzierl MC. Hoff H, et al. Among authors: vratsanos g. J Immunol. 2009 May 1;182(9):5342-51. doi: 10.4049/jimmunol.0801624. J Immunol. 2009. PMID: 19380781 Free article.

8

CD4(+) T cells from lupus-prone mice are hyperresponsive to T cell receptor engagement with low and high affinity peptide antigens: a model to explain spontaneous T cell activation in lupus.

Vratsanos GS, Jung S, Park YM, Craft J. Vratsanos GS, et al. J Exp Med. 2001 Feb 5;193(3):329-37. doi: 10.1084/jem.193.3.329. J Exp Med. 2001. PMID: 11157053 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results